Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Brain Neoplasms 2Pinealoma 1Parotid Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm Metastasis 1Multiple Sclerosis 1Meningioma 1Meningeal Neoplasms 1Medulloblastoma 1Lymphoma 1Liver Neoplasms 1Hypoxia 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Digestive System Diseases 1Choroid Plexus Neoplasms 1Carcinoma, Hepatocellular 1Astrocytoma 1

Interventions

gadolinium ethoxybenzyl DTPA 1gadobutrol 1Tomography, X-Ray Computed 1Indocyanine Green 1Endoscopic Mucosal Resection 1Colonoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Digestive System Diseases × gadobutrol × Clear all
NCT02156739 2025-12-22

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

M.D. Anderson Cancer Center

Phase NA Active not recruiting
100 enrolled
Gastrointestinal

Digestive System Diseases, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡